Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gonzalo Caballero
Observed name:
G. Caballero
Institutions:
Hospital Universitario Miguel Servet,
Fundació Clínic per a la Recerca Biomèdica,
Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer
Observed institutions:
Sanofi (France),
Hospital Universitario Miguel Servet,
Hospital General San Jorge,
Fundació Clínic per a la Recerca Biomèdica,
Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer
ORCID:
0000-0001-6623-780X
Observed ORCID:
0000-0001-6623-780X
OpenAlex ID:
A5109034604
Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera
2015
·
Alberto Alvarez‐Larrán
, Ana Kerguelen
, et al.
·
British Journal of Haematology
·
89
Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea
2022
·
Alberto Alvarez‐Larrán
, Marta Garrote
, et al.
·
Cancer
·
31
PDF
Cell‐cycle distribution of different cell compartments in normal versus reactive bone marrow: A frame of reference for the study of dysplastic hematopoiesis
2011
·
Sergio Matarraz
, Carlos Fernandez
, et al.
·
Cytometry Part B Clinical Cytometry
·
26
The Proliferation Index of Specific Bone Marrow Cell Compartments from Myelodysplastic Syndromes Is Associated with the Diagnostic and Patient Outcome
2012
·
Sergio Matarraz
, Cristina Teodosio
, et al.
·
PLoS ONE
·
25
PDF
Essential thrombocythaemia with mutation in MPL: clinicopathological correlation and comparison with JAK2V617F-mutated and CALR-mutated genotypes
2018
·
Alberto Alvarez-Larran
, Daniel Martínez
, et al.
·
Journal of Clinical Pathology
·
17
Cytoreductive treatment in patients with CALR ‐mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia
2020
·
Alberto Alvarez‐Larrán
, Anna Angona
, et al.
·
British Journal of Haematology
·
15
Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia
2024
·
Marta Santaliestra
, Marta Garrote
, et al.
·
Leukemia
·
6
Hemorragia pulmonar y hemotórax tras ingesta masiva de clopidogrel con fines autolíticos
2009
·
Luis Borderías Clau
, Javier Garrapiz López
, et al.
·
Archivos de Bronconeumología
·
5
Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real -World Setting in Spain: The Venares Study
2021
·
Patricia Baltasar
, María José Terol
, et al.
·
Blood
·
3
Long Term Discontinuation of Eltrombopag after Remission in Primary Immune Thrombocytopenia: 8-Year Follow-up Data from 15 Spanish Centers
2019
·
Tomas Jose Gonzalez-Lopez
, Fernando Fernandez-Fuertes
, et al.
·
Blood
·
3
Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real-World Setting in Spain: An Update of the Venares Study
2022
·
Christelle Ferra
, María José Terol
, et al.
·
Blood
·
2
Excess Mortality in Polycythemia Vera and Essential Thrombocythemia
2018
·
Arturo Pereira
, Carlos Besses Raebel
, et al.
·
Blood
·
2
Pulmonary Haemorrhage and Haemothorax After Massive Ingestion of Clopidogrel as a Suicide Attempt
2009
·
Luis Borderías Clau
, Javier Garrapiz López
, et al.
·
Archivos de Bronconeumología
·
2
Diagnostic reassessment in myeloproliferative neoplasms: the value of functional iron parameters and JAK2 allelic burden
2026
·
Rita González-Resina
, Sara España-Fernández de Valderrama
, et al.
·
Annals of Hematology
·
1
PDF
Safety and efficacy of ponatinib in real world clinical practice. Results from the Spanish Compassionate Use Program. A GELMC study
2016
·
G.-G. J Valentín
, Juan Carlos Hernández‐Boluda
, et al.
·
RISalud Institutional Health Repository of Andalucía
·
1
Pb1558 Characterization of Patients With Immune Thrombocytopenia in Spain. Preliminary Results From Resti: Spanish Registry of Primary Immune Thrombocytopenia
2026
·
Gonzalo Caballero
, Maria Eva Mingot-Castellanos
, et al.
·
Research and Practice in Thrombosis and Haemostasis
PDF
PB3570 Prognostic significance of arterial or venous thrombosis on disease progression, cancer and mortality in myeloproliferative neoplasms
2026
·
Eduardo Arellano-Rodrigo
, Anna Angona
, et al.
·
Research and Practice in Thrombosis and Haemostasis
PDF
Clinical Characteristics and Cardioavscular Events in Patients with Esential Thrombocythemia with <10% Vs. ≥10% JAK2 V617F Allele Burden
2019
·
Blanca Xicoy
, Natalia Estrada
, et al.
·
Blood
Ps1391 Assessment of the Burden of Disease in Terms of Health‐related Quality of Life in Patients With Multiple Myeloma Not Eligible for Asct in Spain: Interim Analysis of Qolmmbus Study
2019
·
J. de la Rubia
, A. Domingo
, et al.
·
HemaSphere
Ps1186 Current Dose Recommendations for Ponatinib in Chronic Myeloid Leukemia Patients Can Diminish Adverse Events While Maintaining Efficacy
2019
·
V. Garcia‐Gutierrez
, J.C. Hernandez‐Boluda
, et al.
·
HemaSphere
Epidemiological Study and Prognostic Markers in Patients Diagnosed with Chronic Ly Lmphocytic Leukemia. EPIGEN Study.
2009
·
Mariola Abio
, Gonzalo Caballero
, et al.
·
Blood
Expression Profiles in Chronic Lymphoid Leukemia by Hematochip Analysis.
2007
·
Patricia Alvarez
, Virginia Leon
, et al.
·
Blood
Automatic reticulocyte counting Comparison between two analyzers based on flow cytometry technology and the manual method
1995
·
James Gomez
, Miquel Gallart
, et al.
Show more works
View as search
Works count:
23
Citation count:
228
H-index:
6
I10-index:
6
Year
Topic
Type